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Introduction
Stomach cancer is one of common cancers and leading 
causes of cancer-related death worldwide, responsible for 
more than one million incident cases and an estimated 
783,000 deaths in 2018 (1). Multiple factors have a role in 
the etiology of stomach cancer. Some of them (e.g., age, sex, 
ethnicity, and genetic factors) are not modifiable, whereas 
nutritional and behavioral factors potentially are (2). Non-
modifiable factors are not preventable but identifying them 
would be helpful to design effective screening programs.
Adult height is an indicator of the interplay between 
genetics and various environmental exposures during 
childhood, such as fetal, nutritional, socioeconomic, and 
psychological circumstances (3). Height is related to the 
risk of mortality and major diseases such as cancers and 
cardiovascular diseases (4,5). Taller adults are reported to 
have increased risk for overall cancer and several common 
cancers. However, findings regarding height and stomach 
cancer are inconsistent.
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Because height range is usually narrow and large 
numbers of events are needed to reliably estimate risk, 
a pooled analysis is warranted. Notably, many studies 
relevant to this question were obscured by titles that 
emphasized other cancers or total cancers. Thus, to clarify 
the association between height and risk of stomach cancer 
comprehensively, we performed a meta-analysis with 
rigorous search strategies. We present the following article 
in accordance with the PRISMA 2009 reporting checklist. 
Available at http://dx.doi.org/10.21037/jgo-20-199. 
Methods
Search strategy
This meta-analysis followed the Meta-analyses Of 
Observational Studies in Epidemiology (MOOSE) 
guidelines (6). We used PubMed, EMBASE and Cochrane 
library databases to identify relevant studies published from 
inception to June 4, 2019 that investigated the association 
between adult height and incident stomach cancer. The 
following keywords were used to extract the articles: 
(“anthropometry” OR “body size” OR “height”) AND 
(“cancer” OR “neoplasm” OR “carcinoma”) AND “risk”. 
No restrictions were applied for language. We also manually 
searched the reference lists of all related articles and reviews 
to identify undetected relevant studies.
Selection and processing
Two authors (MS Seo and DK Park) performed all 
processes independently and resolved disagreements 
through discussion. Studies were included if they met 
the following criteria: (I) reported an association of adult 
height with stomach cancer; (II) reported risk estimates for 
incident stomach cancer, including relative risks (RRs), odds 
ratios (ORs), or hazard ratios (HRs) with 95% confidence 
intervals (CIs). When duplicate records were present for 
the same population, we selected studies with the most 
informative reporting or the larger sample size.
The following variables were extracted from each study: 
the first author’s name; publication year; country where the 
study was performed; study design; participants; number of 
stomach cancer cases; follow-up years; assessment of height; 
the fully adjusted estimate with the corresponding 95% CI; 
and covariates adjusted for the analysis.
We used the Newcastle-Ottawa Scale (NOS) to assess the 
study quality and allowed a total of 9 points to summarize eight 
aspects (with 9 points representing the highest quality) (7). 
An NOS score ≥8 was defined as “high quality”.
Statistical methods
Pooled measure was calculated as the inverse-variance 
weighted mean of the logarithm of RR (95% CI) for 
stomach cancer for a 5-cm-increase in height. We 
considered HRs or ORs equivalent to RRs (8). We unified 
the forms of estimate as an RR for a 5-cm-increase in 
height, to minimize variability in categorization across the 
studies. For studies that did not provide estimates per unit 
of height, we used the Greenland and Longnecker method, 
which requires the case numbers and person-years or non-
cases and RRs with variance estimates for at least three 
height groups (9). We computed subgroup estimates (e.g., 
sex-specific or site-specific estimates) before inclusion in the 
meta-analysis.
We performed statistical analyses using Stata v9.2 
(Stata Corp, College Station, TX, USA). Heterogeneity 
was tested using I2 statistics: I2 >50% is considered a high 
heterogeneity (10). A random effects model was used if 
substantial heterogeneity was observed; otherwise, a fixed 
effects model was applied. We performed subgroup analyses 
according to sex, study design, ethnicity, height assessments, 
body mass index (BMI) adjustment, and study quality. 
We also performed a leave-one-out sensitivity analysis by 
excluding one study at a time to assess results stability and 
potential sources of heterogeneity (11). Visual inspection of 




A flowchart of the study selection procedure is shown 
in Figure 1. After a first screening of duplicate and non-
relevant articles by title and/or abstract, we selected 36 
articles for further assessment and reading of the full text. 
After detailed evaluations, we identified 11 observational 
studies that met all criteria for this meta-analysis (12-22). 
Detailed information about the studies included is 
summarized in Table 1.
Quantitative analysis
The pooled RR was 0.99 (95% CI, 0.95–1.02) with each 
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Figure 1 Flow diagram of the study selection process.





- The duplicates (n=2,337)
- Not relevant based on title (n=21,968)
- Not original paper (n=33)
- Cancer mortality or other topics (n=25)
- No height information (n=32)
Not original data (n=7)
No proper estimate (n=20)
Added manually (n=2)
Full-text articles assessed (n=36)
Articles included in final analysis (n=11)
Table 1 Characteristics of studies on the effect of height on stomach cancer risk 





Adjusted core variates  
other than age and sex
Quality*




131,682 5 Measured BMI, smoking, alcohol,  
exercise, diabetes
9







1,202 12.7 Measured None 7




909 10.5 Self-reported BMI, smoking, SES,  
menarche age
7




152 12 Measured BMI, smoking, alcohol, SES 9
Green, 2011 UK Prospective 1,297,124 
women
1,177 9.4 Self-reported BMI, smoking, alcohol,  
exercise, SES, menarche age
8
Minami, 2008 Japan Case-control 1,730 controls 584 NR Self-reported Smoking, alcohol, occupation, 
family cancer history
4
Merry, 2007 The  
Netherlands
Prospective 120,852 adults 163 13.3 Self-reported BMI, smoking, SES 8
MacInnis, 2006 Australia Prospective 41,295 adults 98 11.3 Measured Exercise, SES 7
Gunnell, 2003 UK Prospective 2,393 men 22 21 Measured BMI, smoking, SES 8
Ji, 1997 China Case-control 1,451 controls 1,124 NR Self-reported Smoking, alcohol, SES,  
chronic gastric diseases
4
Hansson, 1994 Sweden Case-control 679 controls 338 NR Self-reported BMI 4
*, based on the Newcastle-Ottawa Scale (0–9). Me-Can, Metabolic syndrome and Cancer project; NIH-AARP, National Institutes of 
Health-American Association of Retired Persons; WHI, Women’s Health Initiative; BMI, body mass index; SES, socioeconomic status. 
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5-cm increase of adult height (Figure 2). Subgroup analysis 
and sensitivity analysis results are shown in Table 2. A 
“leave-one-out” sensitivity analysis—excluding Choi et al.’s 
study—revealed that the heterogeneity decreased by a half 
and the result showed significance (RR, 0.972; 95% CI, 
0.948–0.997). Overall, subgroup analysis findings depended 
on the study by Choi et al. In the analysis that found a 
significant positive result, the proportional weight of Choi 
et al.’ study was more than 95%. The funnel plot of the 
analysis of height and the risk of stomach cancer is shown in 
Figure 3 and a significant publication bias was not observed 
(P=0.276).
Discussion
In this pooled meta-analysis, we found no significant trend 
indicating an increased stomach cancer risk with increasing 
height. Rather, shorter Caucasians seemed to have higher 
risk for stomach cancer, and other subgroup analyses 
yielded no informative conclusions.
Stomach cancer has distinct epidemiological and clinical 
characteristics by the site (i.e., cardia vs. non-cardia) (23). 
Western countries have a higher proportion of and absolute 
increase in the incidence of cardia stomach cancer relative 
to non-cardia stomach cancer (24,25). Obesity is a major 
risk factor for gastric cardia cancer, possibly through the 
association with gastroesophageal reflux disease (26). Short 
people have a higher BMI and higher obesity risk than 
taller people of the same weight. This is also true for non-
cardia gastric cancer, mainly caused by the infection with 
Helicobacter Pylori (H. pylori) (27). Chronic H. pylori infection 
is associated with poor growth in children (28), and thus 
this might explain the inverse association between height 
and stomach cancer (29). Notably, the NIH-AARP Diet and 
Health cohort reported that patients with non-cardia gastric 
cancer tend to be short in stature (30).
Adult height is determined both by genetics and early 
life exposures, and the outcomes of genetic potentials 
depend on environmental circumstances (3). Mechanisms 
have been proposed to explain the association between adult 
height and cancer (5). One explanation is that an insulin-
like growth factor related to skeletal growth would also 
promote cell proliferation, inhibit apoptosis, and eventually 
lead to cancer (31,32). Cellularity provides another 
potential explanation: taller people have larger organs 
composed of more individual cells, which translates to more 
opportunities for mutations that could lead to malignant 
transformation (33,34). However, it is unclear if the above 
mechanisms contribute to stomach cancer risk.
Our meta-analysis has several limitations. First, the 
current findings are severely depended on only one study. 
In addition, lack of some information did not allow us to 
further address the association (e.g., the tallest group vs. 
the shortest group). Second, although some risk factors 
Figure 2 Forest plot of the association between height and stomach cancer risk. RR refers to the risk for developing stomach cancer per a 5-cm 
increase in height. RR, relative risk; CI, confidence interval.
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Figure 3 Funnel plot with 95% confidence limits for the incidence 
of stomach cancer among the included studies. RR, relative risk.
Table 2 Stomach cancer risk of a 5-cm increment in height
Variables No. of studies Summary RR (95% CI) Heterogeneity, I2 Model
Overall 11 0.99 (0.95–1.02) 64.3% Random
Excluding Choi et al. 10 0.972 (0.948–0.997)# 32.2% Fixed
Sex
Male 7 0.98 (0.94–1.02) 56.3% Random
Female 7 1.04 (1.03–1.05)#choi 45.7% Fixed
Study design
Case-control 4 0.98 (0.90–1.08) 57.0% Random
Prospective 7 0.976 (0.950–1.001) 35.8% Fixed
Ethnicity
Caucasian 8 0.971 (0.947–0.996)# 39.9% Fixed
Asian 3 1.02 (1.02–1.03)#choi 0% Fixed
Height assessment
Self-reported 6 0.98 (0.95–1.01) 11.8% Fixed
Measured 5 1.00 (0.94–1.07) 76.4% Random
BMI adjustment
No 4 1.02 (0.90–1.16) 58.3% Random
Yes 7 1.02 (1.02–1.03)#choi 39.8% Fixed
Study quality*
Low 6 0.97 (0.92–1.03) 53.7% Random
High 5 1.02 (1.02–1.03)#choi 0% Fixed
“Choi” in the subscripts refers to inclusion of the Choi et al. study; however, when it was excluded, the result was null. *, assessed using 






0                            0.1                           0.2                          0.3
Standard error of RR
were controlled, the possibility of unknown or residual 
confounding cannot be ruled out. The current evidence 
is flawed by a lack of data for certain factors, particularly 
the site of stomach cancer (i.e., cardia vs. non-cardia) and 
presence of H. pylori infection. Third, height assessments 
varied across the studies. Self-reporting to assess height may 
have led to overestimation of the actual heights, although 
high correlation has been reported between measured and 
self-reported one (35). Finally, the potential publication 
bias remains, despite no evidence of small study effects with 
the statistical tests in our study. It is still possible that many 
studies with null findings have been left unpublished.
In conclusion, this meta-analysis found no association 
between height and stomach cancer risk. Large-scale 
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multicenter hospital-based studies with detailed clinical 
information are warranted to elucidate subsite- and 
infection-specific associations.
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